Medicus Pharma (Medicus Pharma) Short-Term Capital Lease Obligation : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Short-Term Capital Lease Obligation?

Medicus Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil.

Medicus Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Medicus Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Short-Term Capital Lease Obligation Chart

Medicus Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Medicus Pharma Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial				-	-	-	-	-

Medicus Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Medicus Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicus Pharma (Medicus Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

MDCX:Canada

Address

100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

http://www.medicuspharma.com

Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire • 10-26-2023